glp 1 ontario GLP-1 users at higher risk of scurvy + comparing nutrition to art., #glp1 #ozempic #scurvy #healthnews #nutritiontalk 3 million Canadians use GLP-1

Weight loss is generally one of the first benefits my patients see when they start implementing the tools I give them during a consultation

When using a GLP-1 option, it becomes imperative to ensure the body is getting the vital nutrition it needs, as nutritional intake may be poor due to a reduced appetite

Furthermore, some individuals taking these medications might experience changes in their eating habits due to decreased appetite, sometimes leading to nutritional deficiencies if a balanced diet is not maintained

Research findings reveal substantially elevated gastrointestinal risks demonstrating: Pancreatitis Risk : Patients using GLP-1 agonists showed a 9.09-fold increased risk (adjusted hazard ratio) for developing pancreatitis compared to those using alternative weight loss medications Gastroparesis Development : The study revealed a 3.67-fold increased risk for gastroparesis, often occurring secondary to pancreatic inflammation Bowel Obstruction : A 4.22-fold increased risk for intestinal blockages was documented, frequently accompanying severe gastroparesis cases FDA Adverse Event Reports : Analysis of the FDAs FAERS database through 2024 shows over 900 reported cases of pancreatitis specifically linked to semaglutide use Post-Marketing Surveillance : Real-world data from 2023-2024 indicates that serious gastrointestinal events occur more frequently than initially reported in clinical trials When pancreatitis develops, the inflamed pancreas releases numerous enzymes, toxic substances, and vasoactive compounds including inflammatory cytokines that can damage the autonomic nervous system controlling gastric function

Turns out her compounded version was a higher concentration than she realizedshed actually been taking 1.5x her intended dose